Crescent Innovations Inc, based in Littleton, MA, is a pioneering company that has developed a groundbreaking treatment for osteoarthritis (OA). Their innovative solution utilizes a new material called poly-g-Glutamic Acid (gPGA), a biological polymer that has shown remarkable efficacy in reducing inflammation, a key factor in OA. Pre-clinical studies have demonstrated that gPGA is significantly more effective than the commonly used hyaluronic acid (HA) in alleviating pain. With safety studies completed and clinical deployment on the horizon, Crescent Innovations is poised to revolutionize the treatment of OA.
With a focus on pursuing markets exceeding $10 billion, Crescent Innovations Inc is at the forefront of the fight against osteoarthritis. Their cutting-edge treatment, based on the use of gPGA, has the potential to transform the lives of millions suffering from this debilitating disease. By targeting the key molecular markers of OA and offering superior pain relief compared to existing treatments, Crescent Innovations is set to make a significant impact in the field of medical innovation.
Generated from the website